Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>

Common stock purchase or sale:
Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
2024-06-13 Sale |
2024-06-17 7:35 pm |
uniQure N.V. | QURE | Meek David D. Director |
2,229 | $5.12 | $11,412 | 20,252 (Direct) |
View |
2023-06-16 Sale |
2023-06-20 5:25 pm |
uniQure N.V. | QURE | Meek David D. Director |
2,290 | $18.85 | $43,167 | 39,541 (Direct) |
View |
2023-02-27 Sale |
2023-03-01 4:09 pm |
uniQure N.V. | QURE | Meek David D. Director |
389 | $19.71 | $7,667 | 16,071 (Direct) |
View |
2023-01-17 Sale |
2023-01-19 09:45 am |
Mirati Therapeutics Inc. | MRTX | Meek David D. Chief Executive Officer |
3,179 | $42.38 | $134,715 | 61,792 (Direct) |
View |
2022-12-21 Sale |
2022-12-21 9:20 pm |
Mirati Therapeutics Inc. | MRTX | Meek David D. Chief Executive Officer |
4,616 | $40.41 | $186,552 | 64,971 (Direct) |
View |
2022-07-11 Sale |
2022-07-11 4:07 pm |
Entasis Therapeutics Holdings Inc. | ETTX | Meek David D. Director |
27,500 | $2.2 | $60,500 | 0 (Direct) |
View |
2022-02-28 Sale |
2022-03-02 5:34 pm |
uniQure N.V. | QURE | Meek David D. Director |
602 | $16.7 | $10,053 | 7,380 (Direct) |
View |
2021-03-02 Sale |
2021-03-04 1:58 pm |
uniQure N.V. | QURE | Meek David D. Director |
505 | $37.5 | $18,938 | 6,448 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
2024-06-19 Option Award |
2024-06-21 5:10 pm |
N/A 2034-06-19 |
uniQure N.V. | QURE | Meek David D. Director |
23,920 | $0 | 44,172 (Direct) |
View |
2024-05-15 Option Award |
2024-05-16 5:40 pm |
N/A 2034-05-15 |
Cullinan Therapeutics Inc. | CGEM | Meek David D. Director |
15,618 | $0 | 15,618 (Direct) |
View |
2023-10-16 Option Award |
2023-10-16 5:00 pm |
N/A 2033-10-16 |
Fusion Pharmaceuticals Inc. | FUSN | Meek David D. Director |
34,000 | $0 | 34,000 (Direct) |
View |
2023-06-13 Option Award |
2023-06-20 5:25 pm |
N/A 2033-06-13 |
uniQure N.V. | QURE | Meek David D. Director |
25,760 | $0 | 39,541 (Direct) |
View |
2023-01-20 Option Award |
2023-01-24 4:00 pm |
N/A 2033-01-20 |
Mirati Therapeutics Inc. | MRTX | Meek David D. Chief Executive Officer |
240,612 | $0 | 302,404 (Direct) |
View |
2022-12-19 Option Award |
2022-12-21 9:20 pm |
N/A N/A |
Mirati Therapeutics Inc. | MRTX | Meek David D. Chief Executive Officer |
35,425 | $0 | 64,971 (Direct) |
View |
2022-07-11 Other |
2022-07-11 4:07 pm |
N/A N/A |
Entasis Therapeutics Holdings Inc. | ETTX | Meek David D. Director |
28,307 | $0 | 0 (Direct) |
View |
2022-07-07 Equity Swap |
2022-07-11 4:07 pm |
N/A N/A |
Entasis Therapeutics Holdings Inc. | ETTX | Meek David D. Director |
22,000 | $2.2 | 0 (Direct) |
View |
2022-06-15 Option Award |
2022-06-17 4:22 pm |
N/A 2032-06-15 |
uniQure N.V. | QURE | Meek David D. Director |
26,890 | $0 | 34,270 (Direct) |
View |
2022-02-24 Option Award |
2022-02-28 6:27 pm |
N/A 2032-02-24 |
uniQure N.V. | QURE | Meek David D. Director |
4,179 | $0 | 10,627 (Direct) |
View |
2021-07-16 Option Award |
2022-02-15 4:02 pm |
N/A 2031-07-15 |
Entasis Therapeutics Holdings Inc. | ETTX | Meek David D. Director |
17,307 | $0 | 17,307 (Direct) |
View |
2022-01-18 Option Award |
2022-01-19 4:01 pm |
N/A N/A |
Entasis Therapeutics Holdings Inc. | ETTX | Meek David D. Director |
27,500 | $0 | 49,500 (Direct) |
View |
2022-01-14 Option Award |
2022-01-18 6:20 pm |
N/A 2032-01-13 |
Mirati Therapeutics Inc. | MRTX | Meek David D. Chief Executive Officer |
90,490 | $0 | 90,490 (Direct) |
View |
2021-09-22 Option Award |
2021-09-24 5:11 pm |
N/A 2031-09-21 |
Mirati Therapeutics Inc. | MRTX | Meek David D. Chief Executive Officer |
150,300 | $0 | 150,300 (Direct) |
View |
2021-04-01 Option Award |
2021-04-02 10:34 am |
N/A N/A |
Entasis Therapeutics Holdings Inc. | ETTX | Meek David D. Director |
22,000 | $0 | 22,000 (Direct) |
View |
2021-02-25 Option Award |
2021-03-01 4:00 pm |
N/A 2031-02-25 |
uniQure N.V. | QURE | Meek David D. Director |
6,489 | $0 | 11,060 (Direct) |
View |
2020-06-10 Option Award |
2020-10-06 4:33 pm |
N/A 2030-06-09 |
Entasis Therapeutics Holdings Inc. | ETTX | Meek David D. Director |
11,000 | $0 | 11,000 (Direct) |
View |